Based on indication, the market is categorized into cataract, glaucoma, refractor disorders, and other indications. The glaucoma segment held a significant ophthalmic devices market share in 2023 and is estimated to register the highest CAGR during 2023–2031.
Based on end user, the market is segmented into hospitals and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held a significant ophthalmic devices market share in 2023 and is expected to register the highest CAGR during 2023–2031.
Regional Analysis:
In terms of geography, the ophthalmic devices market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the ophthalmic devices market in this region. The market growth in North America is attributed to the growing burden of eye diseases, such as cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive diseases; increasing geriatric population; the surging acceptance of technologically advanced ophthalmic devices; and the presence of significant market players in the region. With the surging population of people aged 65 and above, cases of age-related diseases such as AMD are on the rise in the US.
